The current issue of JAMA Cardiology (2024)

Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity

Joel T.Rämö,MD, PhD; ShinwanKany,MD, MSc; Cody R.Hou,MSc; et al.

JAMA Cardiol. 2024;9(5):418-427. doi:10.1001/jamacardio.2024.0080

This cohort study investigates the cardiovascular disease associations and genetic determinants of epicardial and pericardial adiposity.

• Editor's Note

  What’s VAT All About—The Clue Is in the Genetics

  Sharlene M.Day,MD

  JAMA Cardiol

Quantitative Coronary Angiography vs Intravascular Ultrasonography to Guide Drug-Eluting Stent Implantation: A Randomized Clinical Trial

Pil HyungLee,MD; Soon JunHong,MD; Hyun-SookKim,MD; et al.

JAMA Cardiol. 2024;9(5):428-435. doi:10.1001/jamacardio.2024.0059

This randomized clinical trial compares 12-month event rates using quantitative coronary angiography guidance during percutaneous coronary intervention with those after intravascular ultrasonography–guided stent implantation.

• Editor's Note

  Moving Beyond Conventional Guesstimation to Guide PCI

  Ajay J.Kirtane,MD, SM; RoxanaMehran,MD

  JAMA Cardiol

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis

MarcoValgimigli,MD, PhD; FeliceGragnano,MD, PhD; MattiaBranca,PhD; et al.

JAMA Cardiol. 2024;9(5):437-448. doi:10.1001/jamacardio.2024.0133

This systematic review and individual patient data meta-analysis assesses the risks and benefits of ticagrelor monotherapy or clopidogrel monotherapy compared with standard dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI).

A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I

Jeremy S.Treger,MD, PhD; Ahmad B.Allaw,MD; PouyanRazminia,MD; et al.

has audio

JAMA Cardiol. 2024;9(5):449-456. doi:10.1001/jamacardio.2024.0265

This diagnostic study aims to develop and validate a simple new criterion, time to notch longer than 75 milliseconds in lead I on electrocardiography, to identify left bundle branch block based on electrophysiological studies of human patients.

• Audio: A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I

Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction

KirstyMcDowell,MBChB; ToruKondo,MD, PhD; AtefehTalebi,PhD; et al.

JAMA Cardiol. 2024;9(5):457-465. doi:10.1001/jamacardio.2024.0284

This prognostic study investigates if models that incorporate routinely collected clinical and laboratory information can predict morbidity and mortality in patients with heart failure and preserved ejection fraction.

Intravascular Imaging–Guided Optimization of Complex Percutaneous Coronary Intervention by Sex: A Subgroup Analysis of the RENOVATE-COMPLEX-PCI Trial

Ji HyunCha,MD; Joo MyungLee,MD, MPH, PhD; Ki HongChoi,MD, PhD; et al.

JAMA Cardiol. 2024;9(5):466-474. doi:10.1001/jamacardio.2024.0291

This prespecified subanalysis of the RENOVATE-COMPLEX-PCI trial evaluates potential differences in outcomes with intravascular imaging–guided percutaneous coronary intervention of complex coronary artery lesions between women and men.

Electrocardiographic Findings in Female Professional Basketball Athletes

Bradley S.Lander,MD; Eamon Y.Duffy,MD, MBA; Jessica A.Hennessey,MD, PhD; et al.

JAMA Cardiol. 2024;9(5):475-479. doi:10.1001/jamacardio.2024.0207

This cross-sectional study describes reference ranges for electrocardiography findings among female professional basketball athletes.

Risk of Cardiac Arrhythmias Among Climbers on Mount Everest

KunjangSherpa,MD, DM; Pasang PhurbaSherpa; TendiSherpa; et al.

JAMA Cardiol. 2024;9(5):480-485. doi:10.1001/jamacardio.2024.0364

This cohort study examines data from climbers at Mount Everest to explore the incidence of tachyarrhythmias and bradyarrhythmias in healthy individuals at high altitudes.

Type 2 Myocardial Infarction—Poorly Understood, Underevaluated, and Too Often Ignored

James A.de Lemos,MD; BertilLindahl,MD, PhD; Nicholas L.Mills,MD, PhD

JAMA Cardiol. 2024;9(5):411-412. doi:10.1001/jamacardio.2024.0127

This Viewpoint discusses diagnosis of type 2 myocardial infarction.

In Memoriam—William H. Gaasch, MD, 1937-2022

Gerard P.Aurigemma,MD; Theo E.Meyer,MD, DPhil, (Oxon); Michael R.Zile,MD

JAMA Cardiol. 2024;9(5):413-414. doi:10.1001/jamacardio.2024.0280

JAMA Cardiology—The Year in Review, 2023

Robert O.Bonow,MD, MS

free access

JAMA Cardiol. 2024;9(5):415-417. doi:10.1001/jamacardio.2024.0340

Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction

ChayakritKrittanawong,MD; Sunil V.Rao,MD; LouaiRazzouk,MD, MPH

has active quiz

JAMA Cardiol. 2024;9(5):486. doi:10.1001/jamacardio.2024.0381

This case report discusses a diagnosis of spontaneous coronary artery dissection in an otherwise healthy man with non–ST elevation myocardial infarction.

Consolidating NRMP Fellowship Matches to Enhance the Applicant Experience

Jeanette L.Calli,MS; Laurie S.Curtin,PhD

JAMA Cardiol. 2024;9(5):487. doi:10.1001/jamacardio.2024.0130

What’s VAT All About—The Clue Is in the Genetics

Sharlene M.Day,MD

JAMA Cardiol. 2024;9(5):427. doi:10.1001/jamacardio.2024.0092

Moving Beyond Conventional Guesstimation to Guide PCI

Ajay J.Kirtane,MD, SM; RoxanaMehran,MD

JAMA Cardiol. 2024;9(5):436. doi:10.1001/jamacardio.2024.0071

Open Access Note Added to Article Information

free access

JAMA Cardiol. 2024;9(5):487. doi:10.1001/jamacardio.2024.0216

Change to Open Access Status

free access

JAMA Cardiol. 2024;9(5):487. doi:10.1001/jamacardio.2024.0582

JAMA Cardiology Peer Reviewers in 2023

free access online only

JAMA Cardiol. 2024;9(5):e240155. doi:10.1001/jamacardio.2024.0155

• Editorial

  JAMA Cardiology—The Year in Review, 2023

  Robert O.Bonow,MD, MS

  JAMA Cardiol

JAMA Cardiology

free access

JAMA Cardiol. 2024;9(5):No Pagination Specified. doi:10.1001/jamacardio.2023.3659